Repurposing Thioridazine (TDZ) as an anti-inflammatory agent.
Baig MS, Roy A, Saqib U, Rajpoot S, Srivastava M, Naim A, Liu D, Saluja R, Faisal SM, Pan Q, Turkowski K, Darwhekar GN, Savai R.
Publications
Publications Link :
The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets.
Thangam EB, Jemima EA, Singh H, Baig MS, Khan M, Mathias CB, Church MK, Saluja R.
NOS1 mediates AP1 nuclear translocation and inflammatory response.
Srivastava M, Baig MS.
Phytochemicals as modulators of M1-M2 macrophages in inflammation.
Saqib U, Sarkar S, Suk K, Mohammad O, Baig MS, Savai R.
Identifying the inhibition of TIR proteins involved in TLR signalling as an anti-inflammatory strategy.
Saqib U, Baig MS.
Matrix Metalloproteinases (MMPs) in Liver Diseases.
Naim A, Pan Q, Baig MS.
Heterotrimeric complex of p38 MAPK, PKCδ, and TIRAP is required for AP1 mediated inflammatory response.
Baig MS, Liu D, Muthu K, Roy A, Saqib U, Naim A, Faisal SM, Srivastava M, Saluja R.
The TLR4-NOS1-AP1 signaling axis regulates macrophage polarization.
Srivastava M, Saqib U, Naim A, Roy A, Liu D, Bhatnagar D, Ravinder R, Baig MS.
Leptospira surface adhesin (Lsa21) induces Toll like receptor 2 and 4 mediated inflammatory responses in macrophages.
Faisal SM, Varma VP, Subathra M, Azam S, Sunkara AK, Akif M, Baig MS, Chang YF.
Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways.
Roy A, Srivastava M, Saqib U, Liu D, Faisal SM, Sugathan S, Bishnoi S, Baig MS.
Non-canonical role of matrix metalloprotease (MMP) in activation and migration of hepatic stellate cells (HSCs).
Baig MS, Yaqoob U, Cao S, Saqib U, Shah VH.
Simultaneous targeting of MyD88 and Nur77 as an effective approach for the treatment of inflammatory diseases.
Uzma S, Baig MS.
NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1.
Baig MS, Zaichick SV, Mao M, de Abreu AL, Bakhshi FR, Hart PC, Saqib U, Deng J, Chatterjee S, Block ML, Vogel SM, Malik AB, Consolaro ME, Christman JW, Minshall RD, Gantner BN, Bonini MG.
Probing PARP1-inhibitor complexes for the development of novel inhibitors.
Saqib U, Baig MS.
Identification of novel inhibitors of dipeptidylcarboxypeptidase of Leishmania donovani via ligand-based virtual screening and biological evaluation.
Gangwar S, Baig MS, Shah P, Biswas S, Batra S, Siddiqi MI, Goyal N.